How to Apply the New Pediatric Eczema Guidelines in Practice

Evidence-based guidelines are only as useful as the framework used to interpret them—and the new pediatric atopic dermatitis recommendations published in the Journal of the American Academy of Dermatology (AAD) are explicit about what they are and what they are not.^1,2 Rather than establishing a standard of care, the authors characterize the document as a set of expert recommendations informed by the best available evidence, acknowledging that individual clinicians, geographies, and patient populations may require different approaches.

Andrew C. Krakowski, MD, of St. Luke's University Health Network, noted that this framing is relatively unusual in the guideline literature and that he found it clarifying. The GRADE system used to score the evidence base rewards large randomized controlled trials, meaning that practices with decades of real-world support but limited trial data—such as oral antibiotics for superinfected eczema—can appear underrepresented in formal recommendations. Torres-Zegarra, of Children's Hospital Colorado, University of Colorado Anschutz, echoed this point, cautioning clinicians against abandoning effective practices simply because they did not meet the threshold for a strong recommendation.

This segment of the HCPLive special report explores the practical implications of that interpretive tension, including how the guidelines can be used as leverage with payers. Krakowski described using the document as a tool to challenge insurance coverage cutoffs that do not align with the expert consensus, arguing that the written endorsement of a recognized academic body carries weight in prior authorization discussions that individual clinical judgment often does not. The conversation reflects a recurring theme throughout the special report: guidelines are most valuable not as prescriptive rules but as evidence-anchored starting points that empower clinicians to advocate for their patients.

Disclosures: Krakowski and Torres-Zegarra have no relevant reported disclosures.

References

1. American Academy of Dermatology Issues First-Ever Pediatric Atopic Dermatitis Guidelines, Highlighting Prevention Strategies and Effective Treatments. American Academy of Dermatology. April 7, 2026. Accessed June 4, 2026. https://www.aad.org/news/aad-issues-first-pediatric-atopic-dermatitis-guidelines.

2. Smith T. First-Ever Pediatric Eczema Guidelines Issued by American Academy of Dermatology. HCPLive. April 10, 2026. Accessed June 4, 2026. https://www.hcplive.com/view/first-ever-pediatric-eczema-guidelines-issued-american-academy-dermatology.